Susquehanna International Group, LLP Cel Sci Corp Call Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$1.63 - $3.08 $12,877 - $24,332	-7,900 Reduced 41.36%	11,200 $21,000
Q4 2023 Feb 14, 2024	BUY	$1.07 - $3.07 $6,527 - $18,727	6,100 Added 46.92%	19,100 $51,000
Q3 2023 Nov 14, 2023	SELL	$1.17 - $2.86 $84,708 - $207,064	-72,400 Reduced 84.78%	13,000 $16,000
Q2 2023 Aug 11, 2023	BUY	$2.11 - $2.83 $18,990 - $25,470	9,000 Added 11.78%	85,400 $205,000
Q1 2023 May 16, 2023	BUY	$2.17 - $3.13 $62,062 - $89,518	28,600 Added 59.83%	76,400 $177,000

Q4 2022 Feb 14, 2023	SELL	$1.99 - $3.52 $300,888 - $532,224	-151,200 Reduced 75.98%	47,800 $112,000
Q3 2022 Nov 14, 2022	BUY	$3.34 - $5.23 $1,336 - $2,092	400 Added 0.2%	199,000 $615,000
Q2 2022 Aug 15, 2022	BUY	$2.58 - $4.99 $336,174 - $650,197	130,300 Added 190.78%	198,600 $894,000
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $137,157 - $268,730	-34,900 Reduced 33.82%	68,300 $268,000
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $1.03 Million - $1.87 Million	-145,500 Reduced 58.5%	103,200 $733,000
Q3 2021 Nov 15, 2021	SELL	$7.64 - $12.49 $6.2 Million - $10.1 Million	-810,900 Reduced 76.53%	248,700 $2.73 Million
Q2 2021 Aug 11, 2021	BUY	$8.68 - $27.49 $2.13 Million - $6.75 Million	245,700 Added 30.19%	1,059,600 $9.2 Million
Q1 2021 May 17, 2021	BUY	$12.0 - $27.64 $2 Million - $4.61 Million	166,700 Added 25.76%	813,900 $12.4 Million
Q4 2020 Feb 16, 2021	SELL	$11.05 - $16.62 $2.51 Million - $3.78 Million	-227,400 Reduced 26.0%	647,200 $7.55 Million
Q3 2020 Nov 16, 2020	SELL	$11.69 - $14.54 $425,516 - $529,256	-36,400 Reduced 4.0%	874,600 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $6.83 Million - $12.3 Million	700,000 Added 331.75%	911,000 $13.6 Million
Q1 2020 May 15, 2020	SELL	$7.54 - $17.05 $6.57 Million - $14.9 Million	-871,600 Reduced 80.51%	211,000 $2.44 Million
Q4 2019 Feb 14, 2020	BUY	$6.71 - $9.55 $1.76 Million - $2.5 Million	262,000 Added 31.93%	1,082,600 $9.91 Million
Q3 2019 Nov 14, 2019	BUY	$6.0 - $9.6 $4.79 Million - $7.66 Million	798,000 Added 3530.97%	820,600 $7.34 Million
Q2 2019 Aug 14, 2019	SELL	$3.77 - $8.67 $401,128 - $922,488	-106,400 Reduced 82.48%	22,600 $189,000
Q1 2019 May 15, 2019	BUY	$2.58 - $3.54 $246,390 - $338,070	95,500 Added 285.07%	129,000 $457,000
Q4 2018 Feb 14, 2019	BUY	$2.65 - $4.26 $88,775 - $142,710	33,500 New	33,500 $96,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.5M

Call Options Held

61.8K

Put Options Held

141K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $47.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account